SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-329260
Filing Date
2013-08-09
Accepted
2013-08-09 16:33:51
Documents
10
Period of Report
2013-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d559107d10q.htm 10-Q 565529
2 EX-31.1 d559107dex311.htm EX-31.1 9813
3 EX-31.2 d559107dex312.htm EX-31.2 10118
4 EX-32.1 d559107dex321.htm EX-32.1 4051
  Complete submission text file 0001193125-13-329260.txt   7058584

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT aria-20130630.xml EX-101.INS 699739
6 XBRL TAXONOMY EXTENSION SCHEMA aria-20130630.xsd EX-101.SCH 48115
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aria-20130630_cal.xml EX-101.CAL 69138
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aria-20130630_def.xml EX-101.DEF 283414
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE aria-20130630_lab.xml EX-101.LAB 383742
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aria-20130630_pre.xml EX-101.PRE 338494
Mailing Address 26 LANDSDOWNE CAMBRIDGE MA 02139
Business Address 26 LANDSDOWNE ST CAMBRIDGE MA 02139 6174940400
ARIAD PHARMACEUTICALS INC (Filer) CIK: 0000884731 (see all company filings)

IRS No.: 223106987 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-21696 | Film No.: 131026981
SIC: 2836 Biological Products, (No Diagnostic Substances)